A Brief Review of Graphene-Based Biosensors Developed for Rapid Detection of COVID-19 Biomarkers

Biosensors (Basel). 2023 Feb 22;13(3):307. doi: 10.3390/bios13030307.

Abstract

The prevalence of mutated species of COVID-19 antigens has provided a strong impetus for identifying a cost-effective, rapid and facile strategy for identifying the viral loads in public places. The ever-changing genetic make-up of SARS-CoV-2 posts a significant challenfge for the research community to identify a robust mechanism to target, bind and confirm the presence of a viral load before it spreads. Synthetic DNA constructs are a novel strategy to design complementary DNA sequences specific for antigens of interest as in this review's case SARS-CoV-2 antigens. Small molecules, complementary DNA and protein-DNA complexes have been known to target analytes in minimal concentrations. This phenomenon can be exploited by nanomaterials which have unique electronic properties such as ballistic conduction. Graphene is one such candidate for designing a device with a very low LOD in the order of zeptomolar and attomolar concentrations. Surface modification will be the significant aspect of the device which needs to have a high degree of sensitivity at the same time as providing a rapid signaling mechanism.

Keywords: COVID-19; SARS; antigens; complementary DNA; protein–DNA.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Biosensing Techniques* / methods
  • COVID-19* / diagnosis
  • DNA, Complementary
  • Graphite*
  • Humans
  • SARS-CoV-2

Substances

  • Graphite
  • DNA, Complementary
  • Biomarkers

Grants and funding

This research was funded by National Research Foundation of Korea (NRF-2022R1G1A1010286 and Ministry of Science and Technology (MOST 109-2221-E-002-MY3) and the National Taiwan University (NTUCC-111L4000-1).